Discover trends, market shifts, and competitive outlooks for the addictions therapeutics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What is the Projected CAGR for the Addictions Therapeutics Market Size from 2025 to 2034?
The market size of therapeutic treatments for addiction has seen robust growth in the past few years. It is projected to enhance from $7.05 billion in 2024 to $7.48 billion in 2025, with a compound annual growth rate (CAGR) of 6.1%. The historic period’s growth can be linked to a rise in the consumption of addictive substances like alcohol, tobacco, and drugs, a heightened awareness, and an increasing incidence of substance abuse disorders. Further influencing factors include marijuana legalization in multiple states and an influx in funding and support for programs treating addiction.
There is a robust development projected in the addictions therapeutics market in the upcoming years, with a growth reaching up to $9.62 billion by 2029 at a compound annual growth rate (CAGR) of 6.5%. Factors contributing to this surge during the forecast period include increasing awareness programs around drug use, the rise of synthetic drugs and novel psychoactive substances, shifts in lifestyle and stress-related issues, a broader array of rehabilitation services, and the incorporation of telehealth strategies in addiction management. The key trends for the forecast duration comprise advancements in diagnostic technology, progress in neuroscience, cooperative engagements between pharmaceutical entities and other relevant actors to tackle addiction concerns, and the launch of innovative drugs in addictions therapeutics arena.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12129&type=smp
What Are the Major Market Drivers Behind the Rising Adoption of Addictions Therapeutics Market?
The addiction therapeutics market is projected to experience growth due to the rising trend of alcohol consumption. The term ‘alcohol consumption’ pertains to the act of consuming beverages that contain ethyl alcohol. The role of addiction therapeutics is to aid in managing addiction related to alcohol, encouraging individuals to cut back on their alcohol intake. This is done by counteracting the depressive effects of alcohol and promoting a balance between two neurotransmitters – glutamate and gamma-aminobutyric acid – in the individual. This balance then reduces cravings for alcohol and can lessen symptoms like insomnia, anxiety, and restlessness associated with alcohol withdrawal. A report published by Statistics Canada in February 2023 indicated that in the fiscal year ending March 31, 2022, retail sales of alcoholic beverages from retail establishments and liquor authorities amounted to $26.1 billion. This figure marked a 2.4% increase from the previous fiscal year. Wine sales also increased, rising by 2.1% to reach $8.1 billion in the same timeframe. Looking at the total sales composition, beer made up 34.9% of total alcohol sales in 2021–2022, followed by wine (31.3%), spirits (25.8%), and ciders and coolers (8.0%). The upsurge in alcohol consumption is therefore driving growth in the addiction therapeutics market.
Which Key Market Segments Comprise the Addictions Therapeutics Market and Drive Its Revenue Growth?
The addictions therapeutics market covered in this report is segmented –
1) By Drug Type: Buprenorphine, Naltrexone, Bupropion, Disulfiram, Nicotine Replacement Products, Varenicline, Other Drugs
2) By Treatment Type: Opioid Addiction Treatment, Alcohol Addiction Treatment, Nicotine Addiction Treatment, Other Substance Addiction Treatment
3) By Treatment Center: Inpatient Treatment Center, Residential Treatment Center, Outpatient Treatment Center
4) By Distribution Channel: Hospital Pharmacies, Medical Stores, Other Distribution Channel
5) By Application: Public, Private, Government
Subsegments:
1) By Buprenorphine: Subutex, Suboxone
2) By Naltrexone: Oral Naltrexone, Extended-Release Naltrexone (Vivitrol)
3) By Bupropion: Wellbutrin, Zyban
4) By Disulfiram: Antabuse
5) By Nicotine Replacement Products: Nicotine Patches, Nicotine Gum, Nicotine Inhalers, Nicotine Lozenges
6) By Varenicline: Chantix (Champix)
7) By Other Drugs: Acamprosate, Topiramate, Gabapentin
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12129&type=smp
Which Areas Are Leading Regions in the Addictions Therapeutics Market Expansion Across the Globe?
North America was the largest region in the addictions therapeutics market in 2024. The regions covered in the addictions therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Strategic Trends Steering theAddictions Therapeutics Market Direction?
Prominent businesses in the addiction therapeutics market are innovating with products like drugs for cocaine use disorders (CUD) to widen their customer reach, boost sales, and escalate revenues. CUD drugs are specialized medications aimed to support those grappling with cocaine addiction or dependency. In a notable development, Tempero Bio, an American biopharmaceutical entity, obtained approval from the U.S. Food and Drug Administration (FDA) for TMP-301 in January 2023. The standout trait of TMP-301, the Company’s potential candidate, is its function as a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM). Explicitly designed to play a crucial role in addressing cocaine use disorders (CUD), TMP-301 is recognized for its strength, selectiveness, and oral availability; all focussed on effectively mitigating the excessive glutamate signaling related to CUD.
View the full report here:
https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report
How Is the Addictions Therapeutics Market Conceptually Defined?
Addiction therapeutics refers to medication, treatment, and management of various forms of addiction to help individuals overcome substance use disorders (SUDs) and other forms of addiction. It involves group and individual therapy sessions to prevent substance misuse.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12129
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
